Psychedelics Hit Mainstream: 10 Celebrities that Treated with and Entered the Psychedelic Industry
4.3 min readPublished On: August 3rd, 2021By News Team
MIAMI–Cannabis has been the gateway to legalization of plant medicine. It took a long time for cannabis to make it out of the prohibition closet at a state level, and as we see, it’s still taking too long for prohibition to end at the federal level. As cannabis continues to be a main focus for legalization in politics, the plant continues to pave the way for psychedelic medicines to shine, like psilocybin, the main compound in magic mushrooms.
It seems like cannabis and psilocybin/magic mushrooms are the most popular plants in America, maybe even globally. As the world wakes up to the truth about the power of cannabis, advocates of psychedelics have a pathway to inform about the power of compounds like psilocybin. As a collective, we are waking up to the fact that humans have criminalized nature and through ballots and legislation, we are changing this one state at a time.
There is a huge shift happening where people are no longer hiding consuming nature for healing. As more celebrities open up about cannabis consumption and businesses, the same is happening in psychedelics. Legal or not, collectively, we the people are demanding change.
What are Psychedelics
Before getting into celebrities, psychedelics should be explained. Psychedelics is a name given by society, learned by the government. Psychedelics are really just plants, with compounds that offer journey’s, also known as trips and highs.
(The author: Veronica Castillo)
Technically defined: psychedelic comes from the Ancient Greek word psychē. Psychē means: mind-manifesting. Psychedelics are a subset of hallucinogenic drugs (though most are plants) whose primary effect is to trigger non-ordinary states of consciousness via serotonin 2A receptor agonism. A few examples of psychedelics:
Magic mushrooms/ psilocybin
Celebrities that Have Consumed Psychedelics for Health/Therapy
Celebrities have been using their platforms to support plant medicines like psilocybin by sharing their experiences. For instance, Psychedelic Spotlight shares a list of celebrities that report consuming psychedelics, and credit psychedelics for changing their lives:
Paul McCartney- who says that psychedelics; “explained the mystery of life.”
Sting- who says that; “ the meaning of the universe cracked open.”
Joe Rogan- who says; “I feel like you can learn something from them, from psilocybin mushrooms, from peyote, from marijuana. They can be used as a tool.”
Mike Tyson- who says; “It takes you to a place that takes you to another dimension. Ever since I did it, I’ve had a miraculous change about me.”
Chelsea Handler- who says; “ things were put into perspective. I learned I needed to have more patience and understanding for my sister.”
(Image: Joe Rogan)
Celebrities and Brands that Have Launched Product Lines, Businesses, and/or Invested in the Psychedelic Industry
As we are seeing, a new type of cannabis business launches everyday. There is a business of almost every type in the cannabis industry, and it looks like psychedelic medicine is headed in that same direction- these are exciting times!
Mind Medicine Inc., backed by Shark Tank’s Kevin O’Leary. Mind Medicine Inc. is a psychedelic research company with multiple FDA approved trials.
Compass Pathways, backed by PayPal billionaire Peter Thiel and Christian Angermayer, the founder of Apeiron Investment Group. Ehave Inc., is testing psilocybin as therapy for treatment-resistant depression.
(Peter Thiel Compass Pathways)
Marley One, launched by Bob Marley’s family, is a line offering products infused with mushrooms.
(Marley One Mushrooms Range)
Mike Zapolin, a known, former Wall Street banker that made millions, left Wall Street to guide celebrities in their psychedelic journey’s, by becoming a psychedelics concierge.
Johnson and Johnson’s, launched an FDA approved ketamine-like nasal spray to treat depression.
Because of the lies told about psychedelics, many have reservations. Let’s close with some psychedelic research:
The U.S National Library of Medicine National Institutes of Health conducted a study on psychedelics for mental health and they found that:
“We did not find use of psychedelics to be an independent risk factor for mental health problems.
“Controlled studies have not suggested that use of psychedelics lead to long-term mental health problems.”
“Psychedelics are not regarded to elicit violence and dangerous behavior leading to suicide or accidental death under the influence of psychedelics is regarded as extremely rare. LSD and psilocybin are consistently ranked in expert assessments as causing less harm to both individual users and society than alcohol, tobacco, and most other common recreational drugs.”
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Douglas, Isle Of Man - Cannabis extraction and extract have gone through exponential growth in the past decade. After being criminalized for a long time, the world saw and moved towards legalizing cannabis in many ...
GRANTS, N.M. - Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, ...
DUBLIN - Global Cannabis Testing Market to Reach $2.8 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Cannabis Testing estimated at US$1.1 Billion in the year 2022, is projected to reach ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more